ResearcherThe University of TokyoNo recent work listed
Mayumi Hoshikawa
Matched on OpenAlex author ID A5023150106. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper
Papers 5
- Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002186↗
- Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. Co-author DOI 10.1097/md.0000000000014369↗
- NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2017.12.083↗
- Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer. Co-author DOI 10.1016/j.jcyt.2017.01.002↗
- Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Co-author DOI 10.18632/oncotarget.11129↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Takahiro Einama · 2 shared papers, 2019–2022 · strength 0.25
- Paper Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer. DOI 10.1097/mpa.0000000000002186↗
- Paper Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. DOI 10.1097/md.0000000000014369↗
- Makoto Nishikawa · 2 shared papers, 2019–2022 · strength 0.25
- Paper Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer. DOI 10.1097/mpa.0000000000002186↗
- Paper Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. DOI 10.1097/md.0000000000014369↗
- Junji Yamamoto · 2 shared papers, 2019–2022 · strength 0.25
- Paper Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer. DOI 10.1097/mpa.0000000000002186↗
- Paper Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. DOI 10.1097/md.0000000000014369↗
- Kiyoshi Hasegawa · 3 shared papers, 2016–2018 · strength 0.20
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083↗
- Paper Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. DOI 10.18632/oncotarget.11129↗
- Taku Aoki · 3 shared papers, 2016–2018 · strength 0.20
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083↗
- Paper Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. DOI 10.18632/oncotarget.11129↗
- Norihiro Kokudo · 3 shared papers, 2016–2018 · strength 0.20
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083↗
- Paper Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. DOI 10.18632/oncotarget.11129↗
- Yoji Kishi · 1 shared paper, 2022 · strength 0.16
- Kazuhiro Kakimi · 2 shared papers, 2017–2018 · strength 0.15
- Hideki Ueno · 1 shared paper, 2019 · strength 0.09
- Akifumi Kimura · 1 shared paper, 2019 · strength 0.09
- Yoshihiro Sakamoto · 1 shared paper, 2016 · strength 0.04
- Ryota Takahashi · 1 shared paper, 2016 · strength 0.04
- Hiroyuki Isayama · 1 shared paper, 2016 · strength 0.04
- Koji Miyabayashi · 1 shared paper, 2016 · strength 0.04
- Keisuke Yamamoto · 1 shared paper, 2016 · strength 0.04
- Kazuhiko Koike · 1 shared paper, 2016 · strength 0.04
- Yousuke Nakai · 1 shared paper, 2016 · strength 0.04
- Hideaki Ijichi · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.